Dive into the dynamic world of biotech with our weekly roundup! Stay ahead of the curve as we bring you the latest in fundraising, mergers and acquisitions, partnering, clinical trials, and groundbreaking science stories.
Weekly Roundup 8 Dec 2023
Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer
Here is Labiotech’s weekly roundup of the latest biotech news. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. The latest biotech news in fundraising Xenon Pharmaceuticals…
